Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
CDiddy's Profile
Displaying 451-500 of 5358 result(s).
CYDY CytoDyn Inc
09/25/2021 8:30:00 PM
Trying to be funny. Making light of (1)
CYDY CytoDyn Inc
09/25/2021 8:22:41 PM
This pisses me off.
CYDY CytoDyn Inc
09/25/2021 3:38:56 PM
Fair point. The fact that there is (4)
CYDY CytoDyn Inc
09/25/2021 10:32:00 AM
I get most of that. Same list I mad (4)
CYDY CytoDyn Inc
09/25/2021 2:14:05 AM
Lol
CYDY CytoDyn Inc
09/24/2021 8:45:49 PM
Lol. I appreciate your concern. I a (1)
CYDY CytoDyn Inc
09/24/2021 2:57:13 PM
I share that concern, and I would v (1)
CYDY CytoDyn Inc
09/24/2021 2:56:32 PM
I don't have a scenario in which I
CYDY CytoDyn Inc
09/24/2021 2:49:58 PM
All great points. And I know that m (6)
CYDY CytoDyn Inc
09/24/2021 2:46:51 PM
This is why you get flak by some he (3)
CYDY CytoDyn Inc
09/24/2021 2:11:07 PM
Good. I hope that I can to the same (5)
CYDY CytoDyn Inc
09/24/2021 1:55:38 PM
Neither side should take this for g (1)
CYDY CytoDyn Inc
09/24/2021 10:17:11 AM
Gotcha. I respect Ohm, but I'm not (1)
CYDY CytoDyn Inc
09/24/2021 10:06:38 AM
How do we know EUA isnt available f (2)
CYDY CytoDyn Inc
09/24/2021 9:46:53 AM
This is the first plan I've seen. A (9)
CYDY CytoDyn Inc
09/24/2021 9:30:46 AM
The argument they are trying to mak
CYDY CytoDyn Inc
09/23/2021 10:46:09 PM
Buuuuurn. I am giddy. I'm going to (4)
CYDY CytoDyn Inc
09/23/2021 10:43:54 PM
I didn't watch the video. The lengt (5)
CYDY CytoDyn Inc
09/23/2021 8:54:31 PM
Heeeeeeeeey, good to see you trding (5)
CYDY CytoDyn Inc
09/23/2021 5:46:31 PM
Brazil is in worse condition and hi (2)
CYDY CytoDyn Inc
09/23/2021 5:38:21 PM
***corrected If I had a scoop of pr (9)
CYDY CytoDyn Inc
09/23/2021 4:59:39 PM
I deleted about 10 posts about Iver (3)
CYDY CytoDyn Inc
09/23/2021 4:48:29 PM
until you from there add in Paulsen (1)
CYDY CytoDyn Inc
09/23/2021 4:25:32 PM
You know what would be awesome. If (16)
CYDY CytoDyn Inc
09/23/2021 10:38:26 AM
Glad to see that. Thank you for sha
CYDY CytoDyn Inc
09/23/2021 10:20:12 AM
Certainly an argument to be made. I (4)
CYDY CytoDyn Inc
09/23/2021 9:35:18 AM
"What would be YOUR priorities (let (3)
CYDY CytoDyn Inc
09/22/2021 10:55:26 PM
I can't even imagine how exciting t (9)
CYDY CytoDyn Inc
09/22/2021 10:53:23 PM
I believe Ive heard that mentioned (1)
CYDY CytoDyn Inc
09/22/2021 9:31:06 PM
My fingers are crossed too. I'm hon
CYDY CytoDyn Inc
09/22/2021 8:04:58 PM
So Ive been told
CYDY CytoDyn Inc
09/22/2021 6:04:46 PM
Fingers crossed. Lets get it done. (2)
CYDY CytoDyn Inc
09/22/2021 3:59:10 PM
Hmm. Thats strange.
CYDY CytoDyn Inc
09/22/2021 3:47:34 PM
Worldometer disagrees https://www.w
CYDY CytoDyn Inc
09/22/2021 3:29:02 PM
I'm not trying to be negative, but (3)
CYDY CytoDyn Inc
09/22/2021 12:49:01 PM
thank you. Samsung paid current. Ho (4)
CYDY CytoDyn Inc
09/22/2021 12:45:17 AM
Oh. Wow. Ok. Thats definitely helpf (1)
CYDY CytoDyn Inc
09/22/2021 12:00:57 AM
Thank you. Good point about the num
CYDY CytoDyn Inc
09/21/2021 11:58:38 PM
Ugh. Yall are starting to sway me. (4)
CYDY CytoDyn Inc
09/21/2021 11:54:48 PM
I could see that happening. I can't (3)
CYDY CytoDyn Inc
09/21/2021 11:40:19 PM
"One patient every 6 days at each l (2)
CYDY CytoDyn Inc
09/21/2021 11:22:12 PM
Of the entire trial? I assume you a
CYDY CytoDyn Inc
09/21/2021 11:19:18 PM
And what would be your guess for mo (1)
CYDY CytoDyn Inc
09/21/2021 10:46:14 PM
My fault for using that term. It wa (5)
CYDY CytoDyn Inc
09/21/2021 9:51:43 PM
I was on the call, but lost interes (2)
CYDY CytoDyn Inc
09/21/2021 9:10:02 PM
Ohm. The groupthink hasn't turned o
CYDY CytoDyn Inc
09/21/2021 9:05:37 PM
I hope you are all right. I want yo (2)
CYDY CytoDyn Inc
09/21/2021 7:52:33 PM
I agree. Hence the reason I disrega (1)
CYDY CytoDyn Inc
09/21/2021 7:44:33 PM
Yall are really going to make me sa (6)
CYDY CytoDyn Inc
09/21/2021 5:49:31 PM
I think this may be overly optimist (2)
Go to page:
  • << First
  • < Previous
  • 9
  • 10
  • Next >

Recent Articles

  • Samsung's Bold $16.5 Billion Chip Deal to Compete in Tech Sector
  • Exploring the Success of CBD Fair Guangzhou's 2025 Edition
  • Economic Impact of Trump's Trade Deal: What Comes Next?
  • Antengene Prepares for Major Presentation on ATG-022 at ESMO
  • How Japan's $550 Billion Deal Can Boost TSMC's Growth in the US
  • Hengrui Pharma and GSK Forge Agreement for Advanced Drug Development
  • Time Is Running Out for Solar Tax Credit Savings with All Energy Solar
  • US and China Seek Trade Solutions Amid Tariff Tensions
  • Introducing Automate's Push PRO: Revolutionary Shade Control
  • Exciting Esports World Cup Promotion from JBO Thailand
  • Harbour BioMed Unveils Strong Profit Predictions for Future Growth
  • Ascletis Begins Significant Obesity Study with ASC30 Drug
  • Elpis Biopharmaceuticals Partners with NCCS for Groundbreaking Research
  • Perseus Mining's Operational Highlights and Financial Overview
  • Shara Magomedov Shines at UFC Night with Epic Victory
  • Investors Urged to Participate in Class Action Against Centene
  • Exploring America’s Hidden Resource Potential and Technology
  • Trump's New Tariff Deal with EU: Impacts and Insights
  • Shaquille O'Neal's Hilarious Showdown with Jimmy Kimmel
  • Empowering Hims & Hers Health Shareholders: Your Legal Guide
  • Public Sentiment on Trump's Tax Cuts: A Closer Look
  • Innovative Cooling Solutions Pioneered by i2Cool for a Sustainable Future
  • Easterly ROCMuni Fund Class Action: Investor Rights Explained
  • Class Action Alert: RxSight Investors Take Action Against Losses
  • Investors of iRobot Corporation Urged to Act Before Deadline
  • Dustin Moskovitz Expands Asana Holdings with Major Purchase
  • Navigating High-Stress Careers: Insights from Executives
  • Banco Comercial Português Updates on Share Buy-Back Programme Activity
  • Centene Corporation Faces Class Action Over Investor Losses
  • Banco Comercial Português (BCP) Shares Buy-Back Program Update
  • Insights into Gilead Sciences, Inc. and Recent Developments
  • Legal Action Initiated Against Flywire Corporation's Officers
  • Replimune Group Faces Legal Action Amid Stock Price Decline
  • Investors Seek Clarity on Simulations Plus Financial Concerns
  • Shocking Survey: How Much Would You Sacrifice For Wealth?
  • Harnessing Natural Testosterone Boosters for Optimal Muscle Growth
  • Neuralink’s Recent Developments and Future Aspirations Explained
  • Global AI Cooperation: China's Vision for the Future of Technology
  • Investment Insights from Experts: Maximize Your $10,000 Now
  • Shiba Inu's 3,000% Growth Potential in Competitive Memecoin Market
  • Investors Seek Justice in Biohaven Ltd. Class Action Lawsuit
  • Class Action Lawsuit Against Hims & Hers Health, Inc. Explained
  • Sarepta Therapeutics Faces Legal Challenges Amidst Controversies
  • Investors Take Note: Class Actions Against Western Asset Management
  • Mereo BioPharma Faces Scrutiny as Investigation Unfolds
  • Centene Corporation Faces Class Action Lawsuit Amidst Losses
  • Investigation Unfolds for Capricor Therapeutics Amid Stock Fluctuations
  • KouShiCare Revolutionizes Dry Eye Treatment with LuminEyes
  • Philanthropic Impact of the Erb Family Foundation on Alzheimer's
  • Celebrating Innovation in Alzheimer’s Research: Awards Announcement
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site